132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page
Session: Round Table Discussions on ATOD Policy Issues
5087.0: Wednesday, November 10, 2004: 12:30 PM-2:00 PM
Roundtable
Round Table Discussions on ATOD Policy Issues
Learning Objectives: See individual abstracts.
Table 1Adult drug court model: The effect of structural differences on program rates *
Natasha H Williams, PhD, JD, MPH
Table 2Exploring drugs in youth culture
Tricia Eitel, Ph D, Robert W. Denniston, MA
Table 3Managed care trends in outpatient substance abuse treatment
Joseph P. Morrissey, PhD, Kathleen C. Thomas, MPH, PhD, Shoou-Yih Daniel Lee, PhD, Alan R. Ellis, MSW
Table 4Changes in the privacy and confidentiality environment for substance abuse programs
Robin Frazier Kandel, JD, Brian J. Balicki, MHS
Table 5State policy mandates for substance abuse outpatient treatment facilities: Are they quality based?
Jamie F. Chriqui, MHS PhD, Shelby Smith, JD, Curtis VanderWaal, PhD, ACSW, Duane C. McBride, PhD
Table 6Rights and wrongs: ATOD policy and its impact on health in communities of color
Makani Themba-Nixon
Table 7Applying civil rights and human rights law to treatment access issues: Dayton, Ohio goes global
Vernellia Ruth Randall, RN, MSN, JD
Table 8Motherhood matters: Human rights law and ATOD policy for women and children
Malika Saada Saar, JD, Makani Themba-Nixon
Table 9Opioid treatment program accreditation evaluation: An overview
Carolyn Lichtenstein, PhD, Namratha Swamy, PhD, Arlene Stanton, PhD, Brian T. Yates, PhD
Table 10Do survey participants under-report illicit drug use? A comparison of self-reports and hair test results
Rita A. Stapulonis, MA
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Alcohol, Tobacco, and Other Drugs
CE Credits:CME, Nursing

The 132nd Annual Meeting (November 6-10, 2004) of APHA